Bone Marrow Grafting for Leukemia and Lymphoma
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
Cellular Adoptive Immunotherapy in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Bortezomib in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Irradiated Donor Lymphocytes and Rituximab in Treating Patients With Relapsed or Refractory Lymphoproliferative Disease
- Status
- TERMINATED
- Phase
- PHASE1
Remission Evaluation Before Intensified Treatment in Lymphoma: Impact of Positron Emission Tomography (PET) Using Fluorine-18-Floro-Deoxyglucose (FDG) in the Therapeutic Prescription. Medico-Economic Randomised Study
- Status
- UNKNOWN
- Phase
- NA
Trial of Oxaliplatin, Cytosine Arabinoside, Dexamethasone With Rituxan (ROAD) in Patients With Relapsed Non-Hodgkins Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Subcutaneous Amifostine Safety Study
- Status
- COMPLETED
- Phase
- PHASE4
Helicobacter - Lymphoma - Radiation Part I: Eradication, Part II: Radiation
- Status
- UNKNOWN
- Phase
- PHASE3
A Study for Aggressive Adult T-cell Leukemia-lymphoma (ATLL)
- Status
- COMPLETED
- Phase
- PHASE3
Denileukin Diftitox in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Study for Newly Diagnosed Follicular Lymphoma Patients With a Large Tumor Burden
- Status
- COMPLETED
- Phase
- PHASE3
Amifostine for Head and Neck Irradiation in Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Rituximab and Cyclophosphamide Followed by Vaccine Therapy in Treating Patients With Relapsed Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Combination Chemotherapy, Bone Marrow Transplant, and Post Transplant Cyclophosphamide for Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic Mastocytosis
- Status
- COMPLETED
- Phase
- PHASE2
Alemtuzumab (Campath-1H) Monoclonal Antibody in Patients With Relapsed and Resistant Classical Hodgkin's Disease
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Malignant Lymphoma (0683-030)
- Status
- COMPLETED
- Phase
- PHASE1
An Investigational Study of a Histone Deacetylase (HDAC) Inhibitor Plus Targretin in Cutaneous T-Cell Lymphoma Patients (0683-016)(TERMINATED)
- Status
- TERMINATED
- Phase
- PHASE1